Autism Consortium 2014 Research Symposium
Date and time
Location
2014 Symposium
Joseph B. Martin Conference Center 77 Avenue Louis Pasteur Boston, MA 02115Description
Autism Consortium Research Symposium
Tuesday , October 21, 2014
Martin Conference Center, Harvard Medical School
The Autism Consortium’s eighth Annual Symposium will be held on Tuesday November 5, 2013, at Harvard Medical School in Boston.
The Symposium will give scientists, clinicians, advocates and families an opportunity to gather and to hear about new innovations and collaborations in autism research and clinical care. The day will begin with a Research and Resource Fair featuring local autism organizations that offer resources on the transition to adulthood, as well as information on enrolling in the latest research studies.
The Morning Session will begin at 8:30 AM. The first speaker will unveil the Boston-Area Autism Connectome, demonstrating the depth and breadth of the research and clinical care community in Boston. Dennis Wall, PhD, will present the Connectome and discuss the collective impact of the research to date and what more needs to be accomplished.
Next, Eric Morrow, MD, PHD, will discuss a new effort called the Rhode Island Consortium for Autism Research and Treatment (RI-CART). The goal is to bringing together physicians, scientists, service providers, educators and parents to collaborate on autism research projects across the state.
Next we will have a panel of teens who will discuss their journey navigating from youth to adulthood.
After a short break there will be a pair of talks, one by Jordan Smoller, MD, ScD, who will discuss the complex interplay of genes, experiences, and the environment that determine mental health development. He will be followed by Jean Frazier, MD, who will round out the morning with a talk on her research on related psychiatric disorders and their impact on transition age youth.
Over lunch there will be a Poster Session featuring important works in progress.
The afternoon session begins at 1:30 PM with a talk by Wendy Chung, MD, PhD on the Simons VIP project, a genetics first approach to the study of autism. The next speaker, Carolyn Bridgemohan, MD, will discuss a new collaborative research project that is looking to identify biomarkers for autism.
After a short break there will be two talks on the role of gene regulation in autism by Matthew Anderson, MD, PhD, and Yea Jin Kaeser-Woo, PhD.
Two final talks will focus on the role of 16p11.2 in autism by Jasmin McCammon, PhD and Ian Blumenthal, PhD.
The day will conclude with a reception for all participants.
Please check this page often for more details, the complete agenda, and registration information.
- See more at: http://www.autismconsortium.org/research-symposium/2013/#sthash.2OBJA8ZR.dpu8:30 AM Welcome
Deirdre Phillips – Executive Director, Autism Consortium
8:45 AM Connectivity and the Rise of Autism Research
Dennis Wall, PhD – Associate Professor, Center for Biomedical Informatics,
Harvard Medical School
9:30 AM Difficult-to-treat autism: from genes to population studies in Rhode Island
Eric Morrow, MD, PhD –Assistant Professor in Molecular Biology and Psychiatry
Institute for Brain Science, Brown University
10:00 AM In their Own Words: Teens Navigating the Transition to Adulthood
Kush Baghat, Darcie Lester, and Michael Mayes
Moderated by Shari King, MA
10:45 AM Break
11:15 AM Psychiatric Genetics: Thinking Outside the Box
Jordan Smoller, MD, ScD - Associate Vice Chair of the MGH Department of Psychiatry and Director of Psychiatric Genetics
11:45 AM Medical and Behavioral Conditions seen in Individuals with Autism Spectrum Disorders
Jean A. Frazier, MD - Vice Chair and Director, Division of Child and Adolescent Psychiatry, Robert M and Shirley S. Siff Endowed Chair in Autism, Professor of Psychiatry and Pediatrics, UMMS/UMMH
12:30 PM Lunch/Poster Session
1:30 PM Simons VIP: A genetics first approach to the study of autism
Wendy Chung, MD, PhD - Herbert Irving Associate Professor of Pediatrics and Medicine, Columbia University
2:15 PM Collaborative Clinical Research: Finding Biomarkers in Autism
Carolyn Bridgemohan, MD - Assistant Professor of Pediatrics, Harvard Medical School; Co-Director, Autism Spectrum Center; Division of Developmental Medicine, Children's Hospital, Boston
3:00 PM BREAK
3:30 PM A Nuclear-Mediated Goldilocks Effect of Ube3a on Social Behavior and Cortical Gene Expression in Idic15 Autism and Angelman Syndrome
Matthew Anderson, MD, PhD – Associate Professor of Pathology, Harvard Medical School; Director of Neuropathology, Beth Israel Deaconess Medical Center
4:00 PM Molecular Tuning of Wnt Signaling by the Autism-associated Gene CDH8
Yea Jin Kaeser-Woo, PhD – Simons Postdoctoral Fellow, MIT
4:15 PM Interaction among 16p11.2 Genes Reveals Key Candidates Affecting Brain Development
Jasmin McCammon, PhD – Postdoctoral Associate, Whitehead Institute for Biomedical Research
4:30 PM Transcriptional Consequences of 16p11.2 Microdeletion/Microduplication Syndrome in Autism Subjects and Mouse Cortex
Ian Blumenthal, BA, BE – Center for Human Genetic Research, MGH
4:45 PM Wrap up
Adjourn to Reception
f8:00 AM Resource and Research Fair
9:00 AM Welcome
Deirdre Phillips – Executive Director, Autism Consortium
9:10 AM iPS Cell Technology and Autism Research
Rudolf Jaenisch, MD - Professor in Biology, Whitehead Institute and the
Department of Biology, Massachusetts Institute of Technology
9:40 AM Update on the Genetics of Autism and other Neurodevelopmental Disorders
Matthew State, MD, PhD - Chair, Department of Psychiatry, University of
California, San Francisco
10:20 AM Paul Marcus, co-founder, Autism Consortium
10:35 AM Break
11:00 AM Autism and Epilepsy: What is the Connection?
Sarah Spence, MD, PhD - Neurology, Boston Children's Hospital
11:30 AM PANEL: Enhancing Clinical Care with Critical Resources
Moderated by Marilyn Augustyn, MD - Director, Division of Developmental
and Behavioral Pediatrics, Department of Pediatrics, Boston Medical Center,
Professor, Boston University School of Medicine
Kelly Hurley - Autism Resource Specialist, Center for Autism and
Neurodevelopmental Disorders (CANDO), Department of Psychiatry, UMass Memorial
Medical Center
Neal Goodman, MS - Autism Resource Specialist, Developmental
Medicine Center, Boston Children's Hospital
Ann Neumeyer, MD - Pediatric Neurology, Medical Director, Lurie
Center for Autism and Massachusetts General Hospital for Children,
Assistant Professor, Harvard Medical School
Jeremy Young - Family Perspective
Josh Lyons - Autism Services Coordinator, TILL, Autism Services Center
12:30 PM Lunch/Poster Session
1:30 PM PANEL: Challenges & Rewards of Translational Research in
Neurodevelopmental Disorders
Moderated by Mustafa Sahin, MD, PhD - Director, Translational
Neuroscience Center, Boston Children's Hospital
Randall Carpenter, MD - Co-founder and Director, Seaside Therapeutics
James Doherty, PhD - Vice President, Pharmacology, Sage Therapeutics, Inc.
Alan Crane, MA, MBA - Partner and Entrepreneur, Polaris Partners
Peter Barrett, PhD - Partner, Life Sciences Group, Atlas Venture
2:45 PM Closing Remarks
Peter Barret, PhD - President, Autism Consortium
3:00 PM Adjourn
The Autism Consortium’s eighth Annual Symposium will be held on Tuesday November 5, 2013, at Harvard Medical School in Boston.
The Symposium will give scientists, clinicians, advocates and families an opportunity to gather and to hear about new innovations and collaborations in autism research and clinical care. The day will begin with a Research and Resource Fair featuring local autism organizations that offer resources on the transition to adulthood, as well as information on enrolling in the latest research studies.
The Morning Session will begin at 8:30 AM. The first speaker will unveil the Boston-Area Autism Connectome, demonstrating the depth and breadth of the research and clinical care community in Boston. Dennis Wall, PhD, will present the Connectome and discuss the collective impact of the research to date and what more needs to be accomplished.
Next, Eric Morrow, MD, PHD, will discuss a new effort called the Rhode Island Consortium for Autism Research and Treatment (RI-CART). The goal is to bringing together physicians, scientists, service providers, educators and parents to collaborate on autism research projects across the state.
Next we will have a panel of teens who will discuss their journey navigating from youth to adulthood.
After a short break there will be a pair of talks, one by Jordan Smoller, MD, ScD, who will discuss the complex interplay of genes, experiences, and the environment that determine mental health development. He will be followed by Jean Frazier, MD, who will round out the morning with a talk on her research on related psychiatric disorders and their impact on transition age youth.
Over lunch there will be a Poster Session featuring important works in progress.
The afternoon session begins at 1:30 PM with a talk by Wendy Chung, MD, PhD on the Simons VIP project, a genetics first approach to the study of autism. The next speaker, Carolyn Bridgemohan, MD, will discuss a new collaborative research project that is looking to identify biomarkers for autism.
After a short break there will be two talks on the role of gene regulation in autism by Matthew Anderson, MD, PhD, and Yea Jin Kaeser-Woo, PhD.
Two final talks will focus on the role of 16p11.2 in autism by Jasmin McCammon, PhD and Ian Blumenthal, PhD.
The day will conclude with a reception for all participants.
Please check this page often for more details, the complete agenda, and registration information.
- See more at: http://www.autismconsortium.org/research-symposium/2013/#sthash.2OBJA8ZR.dpufThe Autism Consortium’s eighth Annual Symposium will be held on Tuesday November 5, 2013, at Harvard Medical School in Boston.
The Symposium will give scientists, clinicians, advocates and families an opportunity to gather and to hear about new innovations and collaborations in autism research and clinical care. The day will begin with a Research and Resource Fair featuring local autism organizations that offer resources on the transition to adulthood, as well as information on enrolling in the latest research studies.
The Morning Session will begin at 8:30 AM. The first speaker will unveil the Boston-Area Autism Connectome, demonstrating the depth and breadth of the research and clinical care community in Boston. Dennis Wall, PhD, will present the Connectome and discuss the collective impact of the research to date and what more needs to be accomplished.
Next, Eric Morrow, MD, PHD, will discuss a new effort called the Rhode Island Consortium for Autism Research and Treatment (RI-CART). The goal is to bringing together physicians, scientists, service providers, educators and parents to collaborate on autism research projects across the state.
Next we will have a panel of teens who will discuss their journey navigating from youth to adulthood.
After a short break there will be a pair of talks, one by Jordan Smoller, MD, ScD, who will discuss the complex interplay of genes, experiences, and the environment that determine mental health development. He will be followed by Jean Frazier, MD, who will round out the morning with a talk on her research on related psychiatric disorders and their impact on transition age youth.
Over lunch there will be a Poster Session featuring important works in progress.
The afternoon session begins at 1:30 PM with a talk by Wendy Chung, MD, PhD on the Simons VIP project, a genetics first approach to the study of autism. The next speaker, Carolyn Bridgemohan, MD, will discuss a new collaborative research project that is looking to identify biomarkers for autism.
After a short break there will be two talks on the role of gene regulation in autism by Matthew Anderson, MD, PhD, and Yea Jin Kaeser-Woo, PhD.
Two final talks will focus on the role of 16p11.2 in autism by Jasmin McCammon, PhD and Ian Blumenthal, PhD.
The day will conclude with a reception for all participants.
Please check this page often for more details, the complete agenda, and registration information.
- See more at: http://www.autismconsortium.org/research-symposium/2013/#sthash.2OBJA8ZR.dpufThe Autism Consortium’s eighth Annual Symposium will be held on Tuesday November 5, 2013, at Harvard Medical School in Boston.
The Symposium will give scientists, clinicians, advocates and families an opportunity to gather and to hear about new innovations and collaborations in autism research and clinical care. The day will begin with a Research and Resource Fair featuring local autism organizations that offer resources on the transition to adulthood, as well as information on enrolling in the latest research studies.
The Morning Session will begin at 8:30 AM. The first speaker will unveil the Boston-Area Autism Connectome, demonstrating the depth and breadth of the research and clinical care community in Boston. Dennis Wall, PhD, will present the Connectome and discuss the collective impact of the research to date and what more needs to be accomplished.
Next, Eric Morrow, MD, PHD, will discuss a new effort called the Rhode Island Consortium for Autism Research and Treatment (RI-CART). The goal is to bringing together physicians, scientists, service providers, educators and parents to collaborate on autism research projects across the state.
Next we will have a panel of teens who will discuss their journey navigating from youth to adulthood.
After a short break there will be a pair of talks, one by Jordan Smoller, MD, ScD, who will discuss the complex interplay of genes, experiences, and the environment that determine mental health development. He will be followed by Jean Frazier, MD, who will round out the morning with a talk on her research on related psychiatric disorders and their impact on transition age youth.
Over lunch there will be a Poster Session featuring important works in progress.
The afternoon session begins at 1:30 PM with a talk by Wendy Chung, MD, PhD on the Simons VIP project, a genetics first approach to the study of autism. The next speaker, Carolyn Bridgemohan, MD, will discuss a new collaborative research project that is looking to identify biomarkers for autism.
After a short break there will be two talks on the role of gene regulation in autism by Matthew Anderson, MD, PhD, and Yea Jin Kaeser-Woo, PhD.
Two final talks will focus on the role of 16p11.2 in autism by Jasmin McCammon, PhD and Ian Blumenthal, PhD.
The day will conclude with a reception for all participants.
Please check this page often for more details, the complete agenda, and registration information.
- See more at: http://www.autismconsortium.org/research-symposium/2013/#sthash.2OBJA8ZR.dpuf For more information
email: autismconsortium@hms.harvard.edu
